GGrantIndex
← Search

SUSTAINED-RELEASE STING AGONIST IMPLANTS ACTIVATE ANTITUMOR IMMUNITY TO TREAT ADVANCED BREAST CANCER IN COMBINATION WITH PARPI

$1,191,979FY2025Defense Health AgencyDOD

The University Of Central Florida Board Of Trustees, Orlando FL

Investigators

View source on USAspending →